MSC 2013: Adult Stem Cell Therapy and Regenerative Medicine

MSC 2013：成体干细胞治疗和再生医学

• 批准号: 8597780
• 负责人: STANTON L. GERSON
• 金额: $ 2.5万
• 依托单位: CASE WESTERN RESERVE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-08-02 至 2014-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8597780
• 关键词: Adult; Award; Biotechnology; Cell Therapy; Clinic; Clinical; Clinical Sciences; Clinical Trials; Devices; Disadvantaged; Doctor of Medicine; Doctor of Philosophy; Drug usage; Electronic Mail; Event; Funding; Goals; Industry; Knowledge; Laboratory Research; Lead; Link; Master of Business Administration; Medical center; Medicine; Minority; Oral; Organ; Physicians; Population; Postdoctoral Fellow; Principal Investigator; Quality of life; Regenerative Medicine; Reporting; Research; Research Personnel; Risk; Shapes; Stem Cell Research; Stem cells; Students; Technology; Therapeutic; Tissue Engineering; Tissues; Translating; Translational Research; Travel; Universities; University Hospitals; Vision; Woman; Work; Writing; adult stem cell; animal tissue; career development; cell preparation; cell type; clinical application; clinical research site; experience; graduate student; human tissue; improved; improved functioning; innovation; interest; lectures; medical schools; meetings; patient population; posters; pre-clinical; product development; programs; public health relevance; repaired; scaffold; stem cell technology; stem cell therapy; symposium

DESCRIPTION (provided by applicant): MSC 2013 is being presented by: The National Center for Regenerative Medicine (NCRM), the Cleveland Clinical and Translational Science Consortium (CTSC), Case Western Reserve University School of Medicine (CWRUSOM), Cleveland Clinic (CC), and University Hospitals Case Medical Center (UHCMC). MSC 2013 will take place in Cleveland, OH, August 19-21, 2013 at the Cleveland Marriott Downtown at Key Center. MSC 2013 Conference Directors include Arnold Caplan, Ph.D.; Robert Deans, Ph.D.; Stanton Gerson, M.D.; Jan Nolta, Ph.D.; Frank Barry, Ph.D.; Mahendra Rao, M.B.B.S., Ph.D.; and Michael Gilkey, M.B.A., M.S. The Conference Directors were chosen due to their active, world-renowned statures in adult stem cell research as well as geographic diversity. Numerous planning meetings and email discussions have already occurred and have shaped the program to serve the field they lead. Vision Statement MSC 2013 will have platform and poster sessions emphasizing preclinical and clinical applications of adult- derived stem cells from a variety of human and animal tissues. MSC 2013 will offer a forum for the exchange and discussion of research, ideas, and cutting-edge breakthroughs in translational regenerative medicine. Target Audience Innovators in the use of stem cells in regenerative medicine The target audience is multi-fold: new and experienced investigators in the adult stem cell therapy field, students (graduate and post-doctoral), physicians, and commercial entities interested in therapeutic opportunities with these cell types. Junior investigators and students will be given a venue to present and discuss their research in poster sessions and invited presentations. Conference Objectives MSC 2013 will * Offer a forum for the exchange and discussion of research, ideas, and cutting-edge breakthroughs in translational regenerative medicine. * Focus on the isolation, characterization, purity, plasticity and clinical uses of adult-derived stem cells from a variety of human and animal tissues. * Emphasize state-of-the-art technologies and clinical utility of these cell preparations for tissue engineering and regenerative medicine. * Feature invited lectures from thought-leaders and provide platform sessions, poster sessions, and a venue for junior investigators and students to present and discuss their research. * Provide a regulatory approach to product development - FDA, commercial risks, endpoints, and patient populations. * Link biotechnology cell therapy industry to investigators and clinical sites including clinical trial status reports. Proposal Specific Aim The specific aim of this R13 proposal is to provide travel and registration support for graduate students, postdoctoral students and clinical fellows to attend MSC 2013, with an emphasis on supporting the participation of women and minority populations. An important consideration is the diversification and participation of students and fellows, so funds will be allocated for disadvantaged and under-represented students to attend the meeting. The goal is to improve career development in the field of regenerative medicine, including broadening their knowledge in stem cell technology and interacting with funded principal investigators. All applicants will be required to submit a poster for presentation and those chosen will present their work at MSC 2013. We plan to provide travel awards for approximately 20 graduate students and post- doctoral fellows to attend and "actively" participate in MSC 2013 through oral and poster presentations, networking events and co-chairing of sessions. They will also be asked to help write the conference proceedings in concert with our Conference Directors.

简介(申请人提供)：MSC 2013由国家再生医学中心(NCRM)、克利夫兰临床与转化科学联盟(CTSC)、凯斯西储大学医学院(CWRUSOM)、克利夫兰诊所(CC)和大学医院病例医学中心(UHCMC)提交。MSC 2013将于2013年8月19日至21日在俄亥俄州克利夫兰举行，地点为Key Center的克利夫兰万豪市中心。MSC 2013会议的董事包括Arnold Caplan博士、Robert Deans博士、Stanton Gerson医学博士、Jan Nolta博士、Frank Barry博士、Mahendra Rao，M.B.S.博士和Michael Gilkey，M.B.A.，M.S.许多规划会议和电子邮件讨论已经发生，并塑造了该项目，以服务于他们领导的领域。 愿景陈述 MSC 2013将举办讲台和海报会议，重点强调从各种人类和动物组织中提取的成体干细胞的临床前和临床应用。MSC 2013将提供一个论坛，交流和讨论转化再生医学的研究、想法和前沿突破。 目标受众 干细胞在再生医学中应用的创新者 目标受众是多方面的：成人干细胞治疗领域的新的和有经验的研究人员，学生(研究生和博士后)，医生，以及对这些细胞类型的治疗机会感兴趣的商业实体。初级调查人员和学生将有机会在海报会议和特邀演讲中介绍和讨论他们的研究。 会议目标 MSC 2013将 *提供一个论坛，交流和讨论转化再生医学的研究、想法和前沿突破。 *重点研究从各种人和动物组织中分离、鉴定、纯度、可塑性和临床应用的成人来源干细胞。 *强调这些用于组织工程和再生医学的细胞制剂的最新技术和临床用途。 *提供思想领袖的特邀讲座，并提供平台会议、海报会议以及初级调查人员和学生介绍和讨论他们的研究的场所。 *提供产品开发的监管方法-FDA、商业风险、终端和患者群体。 *将生物技术细胞治疗行业与研究人员和临床站点联系起来，包括临床试验状态报告。 建议书的具体目标 这项R13提案的具体目的是为研究生、博士后和临床研究员提供参加MSC 2013的旅行和注册支持，重点是支持妇女和少数族裔人口的参与。一个重要的考虑是学生和研究员的多样化和参与，因此将分配资金给贫困和代表不足的学生参加会议。目标是改善再生医学领域的职业发展，包括拓宽他们在干细胞技术方面的知识，并与受资助的主要研究人员进行互动。所有申请者都将 被要求提交一张海报进行展示，被选中的人将在MSC 2013上展示他们的作品。我们计划通过口头和海报演示、网络活动和联合主持会议，为大约20名研究生和博士后研究员提供旅行奖励，让他们参加并“积极”参与2013年的MSC。他们还将被要求与我们的会议主任一起帮助撰写会议记录。